-
Uematsu T., Takai-Todaka R., Haga K., Kobayashi H., Imajima M., Kobayashi N., Katayama K., Hanaki H. Pharmacological Effect of Cepharanthine on SARS-CoV-2–Induced Disease in a Syrian Hamster Model. J Infect Chemother. 2025;31(1):102505.
-
Imai M., Kawakami F., Uematsu T., Matsumoto T., Kawashima R., Kurosaki Y., Tamaki S., Maehana S., Ichikawa T., Hanaki H., Kitazato H., Kubo M. SARS-CoV-2 propagation to the TPH2-positive neurons in the ventral tegmental area induces cell death via GSK3β-dependent accumulation of phosphorylated tau. PLoS One 2024;19(10):e0312834.
-
Kurosaki Y., Matsumoto T., Uematsu T., Kawakami F., Kawashima R., Tamaki S., Imai M., Ichikawa T., Ishii N., Kitasato H., Hanaki H., Kubo M. SARS-CoV-2 infection causes a decline in renal megalin expression and affects vitamin D metabolism in the kidney of K18-hACE2 mice. Sci Rep. 2024;14(1):24313.
-
Ando W., Sogabe M., Ishikawa S., Uematsu T., Furuya H., Yokomori H., Kohgo Y., Otori K., Nakano T., Endo S., Tsubochi H., Okazaki I. Matrix metalloproteinase-1 and microRNA-486-5p in urinary exosomes can be used to detect early lung cancer: A preliminary report. Oncol Lett. 2024;27(3): 127.
-
Jimbo M., Saito S., Uematsu T., Hanaki H., Otori K., Shibuya K., Ando W. Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study. BMC Public Health. 2023;23(1):1489.
-
Uematsu T., Takano T., Matsui H., Kobayashi N., ?mura S., Hanaki H. Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model. J Antibiot. 2023;76(8):481-488.
-
Ando W., Horii T., Jimbo M., Uematsu T., Atsuda K., Hanaki H., Otori K. Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States. Front Public Health. 2022;10:985494.
-
Ando W., Horii T., Uematsu T., Hanaki H., Atsuda K., Otori K. Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States. Sci Rep. 2021;11(1):17968.
-
Iizasa E., Chuma Y., Uematsu T., Kubota M., Kawaguchi H., Umemura M., Toyonaga K., Kiyohara H., Yano I., Colonna M., Sugita M., Matsuzaki G., Yamasaki S., Yoshida H., Hara H. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun. 2021; 12(1):2299.
-
Uematsu T., Tsuchiya K., Kobayashi N., Seiki M., Inoue J., Kaneko S., Sakamoto T. Mint3 depletion-mediated metabolic and oxidative alterations promote pyroptosis and prevent the spread of Listeria monocytogenes infection in macrophages. Cell Death Dis. 2021;12(4):404.